Latest papers

Dysfunction and recovery of synapses in prion disease: implications for neurodegeneration.

Structural factors underlying the species barrier and susceptibility to infection in prion disease.

Reactive hypertrophy of synaptic varicosities within the hippocampus of prion-infected mice.

Faecal CWD prion excretion and inflammation.

Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease.

[Doxycycline versus placebo trial in human prion diseases: a therapeutic challenge].

Biochemistry. What makes a prion infectious?

Generating a prion with bacterially expressed recombinant prion protein.

Prion diseases.

[New evidence of the prion nature of amyotrophic leukospongiosis].

A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report.

PrP interactions with nucleic acids and glycosaminoglycans in function and disease.

Application of “omics” to Prion Biomarker Discovery

Monitoring immune cells trafficking fluorescent prion rods hours after intraperitoneal infection.

Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD(4+) T lymphocytes.

[Acquired human prion diseases--past and present issues].

[Clinical features and PRNP abnormalities of prion diseases]

[Prion disease surveillance in Japan: analysis of 1,241 patients].

[Innovation of therapeutics and prophylaxis for prion diseases]

[History of 50 years of prion disease research].